New technique may spare tiniest babies from breathing tubes
NCT ID NCT04715373
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a method called LISA (Less Invasive Surfactant Administration) in extremely preterm infants (22-25 weeks). Instead of inserting a breathing tube, doctors gave lung medication through a thin catheter while the baby continued on CPAP. The goal was to see if this approach reduces the need for mechanical ventilation in the first 72 hours of life. Sixty infants were enrolled, and the study compared those who received LISA in the delivery room to those who got standard care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Poractant alfa (a natural lung surfactant) given via a thin catheter while the baby stays on CPAP
What this could lead to
If it works, this approach could help extremely preterm babies breathe with less invasive support, potentially lowering the risk of lung damage and other complications.
What could go wrong
This is a small, early feasibility trial with only 60 babies, so results may not apply to all preterm infants. The procedure itself carries risks, such as incorrect catheter placement or breathing instability.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EXTREME PREMATURITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Venkatakrishna Kakkilaya
Dallas, Texas, 75093, United States